Skip to content

Contact +44 (0) 20 7060 7474 email us

Healthcare

Avexa Limited - Financial and Strategic Analysis Review

 

Publication Date July 2009
Publisher Global Markets Direct
Product Type Report
Pages 14
ISBN Number not applicable
Product Code GMD02079

Price

£84.00
approximately: $125 | €92

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Avexa Limited - Financial and Strategic Analysis Review

Summary

Avexa Limited (Avexa) is a drug-discovery company engaged in the discovery and development of anti-infective pharmaceutical medicines for the treatment of serious human infectious diseases. The company's principal research programs focus on the discovery of creative medicines for the treatment of the diseases caused by: Human Immunodeficiency Virus (HIV), Vancomycin- and methicillin-resistant bacteria. It is headquartered at Richmond in Victoria, Australia. In March 2009, the company's merger proposal with Progen is terminated. In May 2009, te company entered into a 6 month, worldwide exclusive option agreement with Tibotec Pharmaceuticals regarding its HIV integrase program

Global Markets Direct's Avexa Limited - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Avexa Limited. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

  • Provides key company information for business intelligence needs.
  • The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
  • The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
  • Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

  • A quick "one-stop-shop" to understand the company.
  • Enhance business/sales activities by understanding customers' businesses better.
  • Get detailed information and financial and strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitor's weaknesses and target the market opportunities available to them.
  • Compare your company's financial trends with those of your peers / competitors.
  • Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

  • List of Tables
  • List of Figures
    • Avexa Limited - Key Facts
    • Avexa Limited - Business Description
    • Avexa Limited - Major Products and Services
    • Avexa Limited - History
    • Avexa Limited - SWOT Analysis
    • SWOT Analysis - Overview
    • Avexa Limited - Strengths
    • Strength - Lead Product Candidate- Apricitabine
    • Strength - Scientific Collaborations
    • Avexa Limited - Weaknesses
    • Weakness - Lack of Products Revenues
    • Avexa Limited - Opportunities
    • Opportunity - Collaboration with TargetDrug
    • Opportunity - Large HIV treatment market
    • Opportunity - Biotech Focus
    • Avexa Limited - Threats
    • Threat - Regulation
    • Threat - Competitive Environment
    • Avexa Limited - Key Competitors
    • Avexa Limited - Key Employees
    • Avexa Limited - Key Employee Biographies
    • Avexa Limited - Company Statement
    • Avexa Limited - Locations And Subsidiaries
    • Head Office
    • Avexa Limited - Financial Ratios
    • Financial Ratios - Capital Market Ratios
    • Financial Ratios - Annual Ratios
    • Financial Ratios - Interim Ratios
    • Financial Ratios - Ratio Charts
    • Appendix
    • Methodology
    • Ratio Definitions
    • About Global Markets Direct
    • Contact Us
    • Disclaimer
  • List of Tables
    • Avexa Limited, Key Facts
    • Avexa Limited, Major Products and Services
    • Avexa Limited, History
    • Avexa Limited, Key Employees
    • Avexa Limited, Key Employee Biographies
    • Avexa Limited, Ratios based on current share price
    • Avexa Limited, Annual Ratios
    • Avexa Limited, Interim Ratios
  • List of Figures
    • Avexa Limited, Ratio Charts
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Contains SWOT Analysis